C3i

Free webinar for quality and compliance professionals in cell and gene therapy. What we'll cover: Spotting risk early, before it becomes a finding Documenting what actually matters Sustaining readiness from development to commercial manufacturing With Yacine Niang, quality and compliance leader at C3i.

Compliance in cell therapy isn't a one-time check. It's something you sustain — from development all the way through commercial manufacturing. Which means the question isn't "are we compliant?" but "can we prove it, today?" Join Yacine Niang (C3i) for a practical hour on risk management and inspection readiness.

If an inspector walked into your facility tomorrow, what would they find? Most quality teams know the answer they'd like to give — and the one they'd actually have to. Closing that gap is a daily practice, not a pre-inspection sprint. Yacine Niang, quality and compliance leader at C3i, shares how she keeps that gap small.

No 80-slide framework. No abstract maturity model. Just the practical tools and approaches Yacine Niang uses to keep cell therapy operations inspection-ready — how to spot risk early, what's actually worth documenting, and what to fix first. You'll leave with ideas you can put to work the same week.

Most teams don't have a documentation problem. They have a too much documentation problem. Binders full of records, and still a scramble when an inspector asks a specific question. Knowing what actually matters — and being able to put your hand on it — is a skill. Yacine Niang (C3i) shares how she decides what to document, what to let go, and how to keep it inspection-ready.

An inspection doesn't send a calendar invite. The only real preparation is the work you do before one is ever scheduled. In this free webinar, Yacine Niang — quality and compliance leader at C3i — walks through the practical tools she uses to spot risk early, document what matters, and stay inspection-ready at any moment.